These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9931877)

  • 41. Phase I/II trial of intraperitoneal 5-Fluorouracil with and without intravenous vasopressin in non-resectable pancreas cancer.
    Oman M; Lundqvist S; Gustavsson B; Hafström LO; Naredi P
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):603-9. PubMed ID: 16047145
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Celiac axis infusion chemotherapy in advanced nonresectable pancreatic cancer.
    Maurer CA; Borner MM; Läuffer J; Friess H; Z'graggen K; Triller J; Büchler MW
    Int J Pancreatol; 1998 Jun; 23(3):181-6. PubMed ID: 9629517
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intra-arterial infusion chemotherapy versus isolated upper abdominal perfusion for advanced pancreatic cancer: a retrospective cohort study on 454 patients.
    Aigner KR; Gailhofer S; Selak E; Aigner K
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2855-2862. PubMed ID: 31506738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Treatment of advanced pancreatic cancer].
    Lersch C; Classen M
    Dtsch Med Wochenschr; 1990 Mar; 115(9):340-2. PubMed ID: 1689634
    [No Abstract]   [Full Text] [Related]  

  • 45. Results of regional chemotherapy using the aortic stop-flow technique in advanced pancreatic carcinoma.
    Meyer F; Gebauer T; Grote R; Martens-Lobenhoffer J; Ridwelski K; Lippert H
    Surg Today; 2006; 36(2):155-61. PubMed ID: 16440163
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [TS-1: S-1 based chemotherapy for far-advanced or relapsed pancreatic cancer].
    Hayashi K; Uchida K; Hatori T; Takasaki K
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():194-7. PubMed ID: 16457248
    [No Abstract]   [Full Text] [Related]  

  • 47. [Sonographic course control of chemotherapy in inoperable pancreatic cancer].
    Braun B
    Med Welt; 1984 Jan; 35(1-2):61-6. PubMed ID: 6700412
    [No Abstract]   [Full Text] [Related]  

  • 48. [A rare case of an isolated metastasis of the head of the pancreas of a breast cancer with obstruction of the efferent bile ducts].
    Hardt W; Parent B; Januschka J; Morath R
    Pathologe; 1993 May; 14(3):167-71. PubMed ID: 8390657
    [No Abstract]   [Full Text] [Related]  

  • 49. [Therapy of locally advanced pancreatic cancer with FOLFIRINOX].
    Strobel O; Büchler MW
    Chirurg; 2016 Aug; 87(8):699. PubMed ID: 27418266
    [No Abstract]   [Full Text] [Related]  

  • 50. Well-differentiated pancreatic islet cell carcinoma: Is there reversibility in mTOR inhibitor resistance?
    Walter T; Scoazec JY; Couderc C; Forestier J; Roche C; Chayvialle JA; Lombard-Bohas C
    Acta Oncol; 2011 Jun; 50(5):731-2. PubMed ID: 21413853
    [No Abstract]   [Full Text] [Related]  

  • 51. [Supportive therapy of pancreatic carcinoma].
    Hentschel E; Meryn S
    Wien Klin Wochenschr; 1994; 106(22):701-3. PubMed ID: 7529956
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Oncology].
    Schwemmle K
    Verh Dtsch Ges Inn Med; 1986; 92():192-202. PubMed ID: 2433847
    [No Abstract]   [Full Text] [Related]  

  • 53. [Systemic chemotherapy for unresectable pancreatic cancer].
    Naruge D; Nagashima F; Furuse J
    Nihon Rinsho; 2015 Mar; 73 Suppl 3():148-51. PubMed ID: 25857004
    [No Abstract]   [Full Text] [Related]  

  • 54. [The treatment of pancreatic carcinoma with cytostatic agents].
    Neijt JP; Blijham GH; Taal BG; Veenhof CH
    Ned Tijdschr Geneeskd; 1987 Mar; 131(11):430-3. PubMed ID: 3561545
    [No Abstract]   [Full Text] [Related]  

  • 55. Advanced pancreatic cancer - how to choose an adequate treatment option.
    Korkeila EA
    World J Gastroenterol; 2015 Oct; 21(38):10709-13. PubMed ID: 26478662
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Use of polyplatillen in chemotherapy of advanced pancreatic cancer].
    Iatsenko LD; Lial'kin SA; Maĭdanevych NM
    Klin Khir; 2008 Jul; (7):20-3. PubMed ID: 19048815
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of time interval between cancer diagnosis and initiation of palliative chemotherapy with overall survival in patients with unresectable pancreatic cancer.
    Lee SH; Chang PH; Chen PT; Lu CH; Hung YS; Tsang NM; Hung CY; Chen JS; Hsu HC; Chen YY; Chou WC
    Cancer Med; 2019 Jul; 8(7):3471-3478. PubMed ID: 31099160
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Regional chemotherapy-induced cure for pancreatic head carcinoma.
    Unal AE; Bayar S; Serinsöz E; Kocaoglu H
    Hepatogastroenterology; 2002; 49(44):556-7. PubMed ID: 11995495
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of pancreatic carcinoma. Is there a role for radiotherapy and chemotherapy?
    Wils JA; Bleiberg H
    Acta Gastroenterol Belg; 1987; 50(1):114-20. PubMed ID: 2447729
    [No Abstract]   [Full Text] [Related]  

  • 60. Metastatic pancreatic cancer: the dilemma of quality vs. quantity of life.
    Shahrokni A; Saif MW
    JOP; 2013 Jul; 14(4):391-4. PubMed ID: 23846935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.